0001235802-11-000066.txt : 20110401
0001235802-11-000066.hdr.sgml : 20110401
20110401165250
ACCESSION NUMBER: 0001235802-11-000066
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110331
FILED AS OF DATE: 20110401
DATE AS OF CHANGE: 20110401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROSENOW EDWARD C III
CENTRAL INDEX KEY: 0001241294
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31812
FILM NUMBER: 11732201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001023024
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 582301143
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 BARCLAY BLVD STE 280
CITY: LINCOLNSHIRE
STATE: IL
ZIP: 60069
BUSINESS PHONE: 8474780500
MAIL ADDRESS:
STREET 1: 111 BARCLAY BLVD STE 280
CITY: LINCOLNSHIRE
STATE: IL
ZIP: 60069
FORMER COMPANY:
FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC
DATE OF NAME CHANGE: 19991027
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0303
4
2011-03-31
0
0001023024
BIOSANTE PHARMACEUTICALS INC
BPAX
0001241294
ROSENOW EDWARD C III
C/O BIOSANTE PHARMACEUTICALS, INC.
111 BARCLAY BOULEVARD
LINCOLNSHIRE
IL
60069
1
0
0
0
Common Stock
17540
D
Non-Statutory Stock Option (right to buy)
1.98
2011-03-31
4
A
0
25000
0
A
2012-03-31
2021-03-30
Common Stock
25000
25000
D
/s/ Phillip B. Donenberg, attorney-in-fact
2011-03-31